Covis Pharma
Covis Pharma's Overview
Covis Pharma is a global specialty pharmaceutical company that markets and distributes a portfolio of branded products used to treat a wide range of life-threatening and chronic illnesses. The company is focused on acquiring and commercializing mature, branded pharmaceutical products, aiming to improve patient outcomes and enhance quality of life. They operate across various therapeutic areas and maintain a strong commitment to healthcare providers and the patients they serve.
Where is Covis Pharma's Headquarters?
HQ Function
Serves as a key operational hub for Covis Pharma's European and international operations, including commercial activities, strategic planning, and corporate functions.
Notable Features:
Located in a modern business district, likely featuring contemporary office spaces designed for collaboration and efficiency, characteristic of pharmaceutical HQs in Zug. The office supports global operations.
Work Culture:
The work culture at Covis Pharma likely emphasizes innovation, patient-centricity, collaboration, and a commitment to quality, reflecting the pharmaceutical industry's standards. Employees may experience a dynamic, results-oriented, and international environment.
HQ Significance:
The Zug operational headquarters is significant due to its location in a key European pharmaceutical cluster, providing access to talent, industry partners, and a robust business infrastructure. It underpins their European and global market presence.
Values Reflected in HQ: The headquarters' presence in a premier European business hub likely reflects Covis Pharma's commitment to operational excellence, global reach, and maintaining a professional environment conducive to advancing healthcare solutions.
Location:
Covis Pharma operates on a global scale, with key operational hubs in Zug, Switzerland, and Bridgewater, NJ, USA, and its registered headquarters in Luxembourg. The company supports a worldwide network for the marketing, distribution, and commercialization of its pharmaceutical products, focusing on ensuring patient access to their therapies across various international markets.
Street Address:
Bahnhofstrasse 14
City:
Zug
State/Province:
Zug
Country:
Switzerland
Covis Pharma's Global Presence
Bridgewater, New Jersey, USA
Address: 500 US Highway 202/206, Suite 210, Bridgewater, NJ 08807
Manages the company's product portfolio and strategic initiatives within the U.S., a key global pharmaceutical market.
Luxembourg City, Luxembourg
Address: 30, Boulevard Royal, L-2449 Luxembourg
Serves as the formal corporate seat, leveraging Luxembourg's strategic location and business environment for international holding companies.
Buying Intent Signals for Covis Pharma
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Covis Pharma
As of April 2025, Covis Pharma' leadership includes:
Investors of Covis Pharma
Covis Pharma has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Covis Pharma appointed a new Head of R&D and Chief Medical Officer in June 2023, a key addition to its leadership team. No major executive exits have been publicly announced in the last 12 months (as of mid-2024).
New Appointments:
Technology (Tech Stack) used by Covis Pharma
Discover the tools Covis Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Covis Pharma Email Formats and Examples
Covis Pharma likely utilizes standard corporate email formats for its employees. While the exact primary format isn't publicly disclosed, common patterns in the pharmaceutical industry include combinations of first name, last name, and initials with the company domain.
[first_initial][last]@covispharma.com
Format
jdoe@covispharma.com
Example
75%
Success rate
News and media
covispharma.com (Press Release) • June 27, 2023
Covis Pharma Group Appoints Howard L. Mayer, M.D. as Head of R&D and Chief Medical Officer
Covis Pharma announced the appointment of Howard L. Mayer, M.D., as its new Head of Research & Development and Chief Medical Officer, effective June 27, 2023. Dr. Mayer will lead the company's R&D strategy and global medical affairs....more
FDA.gov News Release • April 7, 2023
FDA Announces Decision to Withdraw Approval of Covis Pharma's Makena
The U.S. Food and Drug Administration's Commissioner and Chief Scientist announced their decision to withdraw approval for Makena (hydroxyprogesterone caproate injection), a drug marketed by Covis Pharma, as postmarket studies failed to verify clinical benefit in reducing the risk of preterm birth....more
PR Newswire • March 14, 2023
Covis Pharma Group Announces Launch of Authorized Generic of Treprostinil Injection
Covis Pharma Group announced the U.S. launch of an authorized generic version of Treprostinil Injection, indicated for the treatment of pulmonary arterial hypertension (PAH). This initiative aims to expand patient access to this critical therapy....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Covis Pharma, are just a search away.